Eris Lifesciences posts QoQ fall in consolidated PAT to Rs. 80.29 crores

Eris Lifesciences Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 314.010 crores during the period ended March 31, 2022 as compared to Rs. 337.335 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 80.296 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 100.765 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 5.91 for the period ended March 31, 2022 as compared to Rs. 7.41 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 314.010 crs	₹337.335 crs	-6.91%
Net Profit	₹80.296 crs	₹100.765 crs	-20.31%
EPS	₹5.91	₹7.41	-20.24%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 314.010 crores during the period ended March 31, 2022 as compared to Rs.280.419 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.80.296 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.68.247 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.5.91 for the period ended March 31, 2022 as compared to Rs.5.03 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 314.010 crs	₹280.419 crs	11.98%
Net Profit	₹80.296 crs	₹68.247 crs	17.65%
EPS	₹5.91	₹5.03	17.50%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.1373.137 crores during the Financial Year ended March 31, 2022 as compared to Rs.1220.571 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.406.113 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.355.135 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.29.88 for the Financial Year ended March 31, 2022 as compared to Rs.26.14 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹1373.137 crs	₹1220.571 crs	12.50%
Net Profit	₹406.113 crs	₹355.135 crs	14.35%
EPS	₹29.88	₹26.14	14.31%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 673.70 as compared to the previous close of Rs. 675.70. The total number of shares traded during the day was 15314 in over 1151 trades.

The stock hit an intraday high of Rs. 687.55 and intraday low of 667.55. The net turnover during the day was Rs. 10361594.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q4FY22 FY2022 ResultUpdate